NCT03424005 2026-03-16
Morpheus-panBC
Hoffmann-La Roche
Phase 1/2 Recruiting
Clinical Trials
10 trialsNCT07471815 2026-03-13
Camrelizumab Plus Risedronate and Chemotherapy for Triple-Negative Breast Cancer: An Exploratory Clinical Study on Mechanisms and Efficacy
Harbin Medical University
Phase 2 Active not recruiting
NCT01928589 2026-03-06
Partial Irradiation and Sequential vs. Concurrent Chemo Early Breast Cancer
Indiana University
Phase NA Active not recruiting
NCT04703244 2026-03-03
Development of Patient Derived Xenografts (PDX) in Patients With Breast Cancer
Mayo Clinic
Recruiting
NCT05710328 2026-03-02
Testing the Role of FDG-PET/CT to Predict Response to Therapy Prior to Surgery for HER2-positive Breast Cancer, The DIRECT Trial
Eastern Cooperative Oncology Group
Phase 2 Active not recruiting
NCT07342283 2026-03-02
QL1706 Plus Chemotherapy as Neoadjuvant Therapy in Triple-Negative Breast Cancer
Affiliated Hospital of Nantong University
Phase 2 Recruiting
NCT06627712 2026-01-30
SBRT Combined With PD-1 Inhibitor and Chemotherapy in Early-stage TNBC
West China Hospital
Phase 3 Recruiting
NCT07378306 2026-01-30
FACT-TN
Sun Yat-sen University
Phase 2 Not yet recruiting
NCT07372079 2026-01-28
Neoadjuvant Therapy for Early Triple-Negative Breast Cancer: A Response-Guided Approach Using Iparomlimab and Tuvonralimab Injection in Combination With Chemotherapy
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Not yet recruiting
NCT05826964 2026-01-13
Levels of Circulating Tumor DNA as a Predictive Marker for Early Switch in Treatment for Patients With Metastatic (Stage IV) Breast Cancer
University of Miami
Phase 2 Active not recruiting